PinGe Intelligence Launches Robotic Microbial Smart Laboratory Platform: Micro-RB365/Ratio

With the rapid emergence of new-generation technologies such as robotics and artificial intelligence,Testing and Inspection SectorTransformation Brings New Opportunities and Possibilities.Microbiological TestingAs an important indicator for measuring the hygienic quality of products and the safety of inspected products, it is widely used inFood Safety, Medical and Health, Inspection and Quarantine, Environmental Monitoring, Border Inspection and Customsand many other fields. To address issues such as the cumbersome and time-consuming nature of microbial preparation operations, as well as the significant impact of human factors, and to meet the requirements for batch experiments, high-throughput screening, and data traceability, Guangxi Character Zhizao Life Science R & D Co., Ltd. (hereinafter referred to as “Character Zhizao”), founded by the robotics team of a listed company,TheIntegration of frontier technologies such as robotics, machine learning, and big data with microbial detection, centered on robotic execution equipment and big data analytics systems., launched the industry-leading"Robotic Microbial Preparation Platform" for Smart Laboratory Products （Micro-RB365/Ratio）。

Robotic Microbial Preparation PlatformIt enables intelligent sample preparation for microbiological testing of food, pharmaceuticals, cosmetics, and environmental samples. This platform integrates automation, intelligence, high-throughput capacity, high efficiency, and broad applicability. The robotic system can automatically match different test samples with corresponding flexible experimental protocols, while also supporting data traceability and remote experiment management.

July 4 (Thursday) 19:30, Artery Select New Product Review Issue 72, invites Liang Zhihong, CEO of Guangxi Character Zhizao Life Science R & D Co., Ltd.; Gan Yongqi, Deputy Chief Pharmacist of the Microbiology Department at Guangxi Institute for Drug Control; and Lu Rifan, Marketing Manager of Character Zhizao Life Science R & D Co., Ltd., to bring“Robotic Microbial Testing Preparation Platform and Robotic Smart Laboratory”product promotion.

· ImplementationUnattended, Autonomous Laboratory Testing by Robots

· Robotic detection offers high standardization, precision, repeatability, and consistency.

· Supports flexible experiments with multiple projects, diverse samples, and varied measurements.

· Effectively Prevent Cross-Contamination

· Full-Process Monitoring of Experimental Procedures (Data + Video)

· Real-time Data Acquisition and Feedback in Experiments

· Interconnectable with LIMS, and capable of data sharing with drug regulatory systems and government platforms

· Internet-EnabledRemote Laboratory Management and Monitoring

· AvailableClass 9Experimental Project(Fungi, colonies, heat-resistant coliforms, Escherichia coli, Escherichia coli, bile-tolerant, Salmonella, Candida albicans, Clostridium)

· Disposable sample loading capacity up to32 itemsTest Samples (Customizable on Demand),24HWork

· Continuous operation with a single sample loading3.5+ hours

· Average Preparation Time per Sample5-7 minutes ((96–64 samples completed in 8 hours)

· 80 itemsExperimental Storage Location,180 unitsLaboratory Glassware

· Precision Automated Dispensing of Culture Media and Diluents

· Supports experiments using various vessels, including Erlenmeyer flasks, Petri dishes, and test tubes.

1. A Versatile, Broadly Applicable Microbial Preparation Platform

Suitable for sample preparation in microbiological testing of food, pharmaceuticals, cosmetics, and other categories; compatible with common microbiological containers such as Erlenmeyer flasks, Petri dishes, test tubes, and homogeneous bags; adaptable to various experimental workflows, with support for customizable experiment templates.

2. Single Sampling, Parallel Preparation of Multiple Items

A single sample can be used to simultaneously prepare multiple test items in parallel. Depending on the specific experimental or testing requirements, culture media, test solutions, positive and negative controls, serial dilutions, and other materials for multiple assays can be prepared concurrently.

3. Flexible experimental combinations with full-process data traceability

Customizable gradient dilution ratios, experimental measurements, sequences, rounds, and combinations enable diverse experimental setups; digital recording of experimental processes combined with video monitoring ensures full data traceability.

4. Future Healthcare Top 100 · Top 5 Life Science Instruments

Robotic Microbial Preparation Platform Wins the 2024 Top 100 Future Healthcare Innovation Award, Ranking Among the Top 5 in Life Science Instruments and Equipment

Scan the QR code on the poster to add the assistant and reserve a spot for the live stream.

Liang Zhihong

CEO of Guangxi Character Zhizao Life Science R & D Co., Ltd.

As one of the core members of China’s earliest robotics entrepreneurship teams, he previously served as the regional head for Huanghe Whirlwind, a publicly listed company. He pioneered and implemented the “Intelligent Manufacturing Fund” model, achieving over RMB 100 million in performance within three years. He led his team to win the highest award for Regional Innovative Talent Teams and was received by President Xi Jinping.He founded Character Zhizao Life Sciences, a company dedicated to integrating robotics technology with life sciences. Holding multiple patents, the company has launched more than ten innovative products across several product lines, including the globally debut SUPER X-100 ultra-soft robotic laboratory platform and the microbial robotic detection platform. It is the first enterprise in the region to obtain a medical device license for robotics. The company has been honored with numerous awards, including First Place in the SCGC Deep Blue Laboratory’s “Future Star” program, First Prize in the China–ASEAN Smart City Innovation Competition, and Second Place in the Southwest Division of the National “Specialized, Refined, Differential, and Innovative” Dark Horse Competition.

Gan Yongqi

Deputy Chief Pharmacist, Microbiology Laboratory, Guangxi Institute for Drug Control

Master of Microbiology and Biochemical Pharmacy, Master’s Supervisor. Deputy Chief Pharmacist, Microbiology Laboratory, Guangxi Institute for Drug Control; Guangxi GMP Inspector, Standardization Expert, and Member of the Biosafety Expert Committee. Primarily engaged in microbiological testing, research on drug testing methods, and standard development. Published 20 academic papers as the first author; led or participated in multiple research projects commissioned by the Chinese Pharmacopoeia Commission, the Guangxi Science and Technology Department, and the Nanning Science and Technology Bureau.

Lu Rifan

Marketing Manager, Guangxi Character Zhizao Life Science R & D Co., Ltd.

Head of the Robotic Microbiology Product Line at Character Zhizao, responsible for overseeing the robotic microbiology product portfolio. Previously employed at Fosun Diagnostics, where he was extensively involved in the development of a series of products, including fully automated microbial antimicrobial susceptibility testing systems, integrated biochemistry and immunoassay analyzers, and fully automated bacterial incubators. He possesses extensive experience in the development of microbiological testing products.

Guangxi Character Zhizao Life Science R & D Co., Ltd. is a high-tech enterprise empowered by interdisciplinary integration and fused innovation. The company focuses on the smart laboratory sector, positioning itself from inception to drive collaborative innovation through engineering, informatics, and biological thinking, deeply integrating advanced equipment manufacturing and digital technologies with life sciences. It is committed to empowering life sciences and biopharmaceuticals with robotics, big data, and machine learning technologies, creating new tools with new technologies and forming new models with new thinking, so as to provide better, faster, more accurate, and more reliable robotic testing equipment for medical diagnostics.

The company’s founding team comprises members from the intelligent robotics manufacturing and digitalization divisions of a publicly listed company, integrated with experts in biopharmaceuticals. The founder, formerly a senior executive at a publicly listed company, represented the intelligent manufacturing sector in a report to President Xi Jinping. The team has received the highest municipal award for innovative talent teams. The company holds multiple patents and has launched two product lines—including the world’s first ultra-flexible robotic experimental platform, SUPER X-100, and an intelligent microbial detection robotic platform—comprising more than ten innovative products. It is the first enterprise in its provincial region to obtain medical device certification for robotics.

The company was awarded first place as the “Future Star” by Liu Gang’s Shenlan Laboratory of Shenzhen Capital Group (SCGC), won the First Prize in the China-ASEAN New Smart City Innovation Competition, secured the Second Prize in the Southwest Regional Division of the National Specialized, Refined, Differential, and Innovative “Dark Horse” Competition, ranked among the Top 5 in Life Science Instruments on the 2024 Future Healthcare 100 list, was recognized as a VCBeat 2024 VBEF Healthcare Industry Innovative Product, and was shortlisted among the Top 30 in the inaugural KingMed Diagnostics Medical AI Competition.

“Artery Select New Product Debut” is a live-streaming program under the “Artery Select” brand, dedicated to supporting healthcare enterprises in launching innovative products. The program’s mission is: to empower the milestone launch of every medical innovation product.

Scan the QR code below to contact the assistant and schedule a live stream (if already added, please proactively reach out to the assistant).

Scan the QR code below to download the VCBeat app and register to watch the live stream.

Send a screenshot of the live stream to the assistant to enter the lucky draw for a chance to win a [15-day trial membership of VBInsight].